Avadel Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
23.258.246.375
Price/Sales ratio
2.702.011.681.48
Earnings per Share (EPS)
$0.59$1.66$2.15$2.75

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-7.3012.18-10.384.93-1.01-8.4950.37-6.11-3.13-7.06-2.51-2.51
Price/Sales ratio
41.982.862.851.920.934.7615.85N/AN/A40.48N/A4.76
Price/Book Value ratio
24.917.3010.183.9234.63-9.672.186.04-20.3412.90-26.99-9.67
Price/Cash Flow ratio
-58.425.8722.6719.91-1.16-7.36-7.26-6.11-6.12-8.80-4.82-4.82
Price/Free Cash Flow ratio
-50.245.9924.21-8.95-0.93-7.36-7.24-6.11-6.05-8.80-4.79-4.79
Price/Earnings Growth ratio
-0.18-0.080.05-0.010.000.13-0.430.00-0.040.550.050.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
77.10%93.69%91.18%90.56%83.03%79.52%74.29%N/AN/A96.97%N/A79.52%
Operating Profit Margin
-635.24%41.24%-3.30%51.11%-101.60%-28.41%-164.14%N/AN/A-492.96%N/A-101.60%
Pretax Profit Margin
-611.37%45.25%-6.46%52.95%-109.61%-65.15%-22.75%N/AN/A-574.96%N/A-109.61%
Net Profit Margin
-574.65%23.47%-27.47%38.93%-92.28%-56.11%31.46%N/AN/A-573.17%N/A-92.28%
Effective Tax Rate
1.55%48.13%-324.73%26.47%15.80%13.88%238.29%16.98%-23.35%0.31%-29.58%13.88%
Return on Assets
-48.73%18.91%-16.81%26.67%-50.08%-21.94%2.25%-31.27%-103.52%-97.31%-171.20%-21.94%
Return On Equity
-341.05%59.91%-98.11%79.53%-3428.20%113.79%4.33%-98.83%650.10%-182.67%-4964.93%113.79%
Return on Capital Employed
-90.80%42.99%-2.71%53.21%-69.06%-14.57%-12.36%-37.80%-128.01%-107.82%-37.18%-69.06%
Liquidity Ratios
Current Ratio
1.583.402.901.433.252.2817.43N/AN/AN/A1.802.28
Quick Ratio
1.493.322.851.363.122.1917.439.161.803.351.722.19
Cash ratio
0.561.330.620.190.240.274.742.411.320.841.320.24
Days of Sales Outstanding
214.6215.7743.3334.8849.1751.0454.35N/AN/A175.23N/A51.04
Days of Inventory outstanding
726.00138.8689.76137.8699.39107.46N/AN/AN/A4.47KN/A107.46
Operating Cycle
940.63154.64133.09172.74148.56158.5154.35N/AN/A4.65KN/A158.51
Days of Payables Outstanding
865.72168.71195.75167.4172.99183.62186.503.43K1.92K4.93KN/A183.62
Cash Conversion Cycle
74.90-14.06-62.655.3275.57-25.11-132.14N/AN/A-279.07N/A-25.11
Debt Ratios
Debt Ratio
0.680.000.000.000.600.800.410.570.980.201.150.60
Debt Equity Ratio
4.750.010.010.0041.66-4.180.791.83-6.150.38-7.27-4.18
Long-term Debt to Capitalization
0.750.000.010.000.971.310.440.641.300.271.290.97
Total Debt to Capitalization
0.820.010.010.000.971.310.440.641.190.271.190.97
Interest Coverage Ratio
-3.5916.2546.0257.99-5.70-1.34-2.82N/AN/AN/A-1.60-5.70
Cash Flow to Debt Ratio
-0.0875.3923.1962.40-0.71-0.31-0.37-0.53-0.53-3.81-0.90-0.31
Company Equity Multiplier
6.993.165.832.9868.45-5.181.923.16-6.271.87-6.27-5.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.710.480.120.09-0.80-0.64-2.18N/AN/A-4.59N/A-0.80
Free Cash Flow / Operating Cash Flow Ratio
1.160.980.93-2.221.241.001.001.001.0111.001.00
Cash Flow Coverage Ratio
-0.0875.3923.1962.40-0.71-0.31-0.37-0.53-0.53-3.81-0.90-0.31
Short Term Coverage Ratio
-0.25194.2270.52150.10-780.33-59.41-102.81-85.9-1.82-137.59-3.06-780.33
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A